| Structure | Chemical Name | CAS | MF |
|
2-((2-(benzyloxy)-4,6-dimethylpyridin-3-yl)methyl)-7-bromo-5,8-dichloro-3,4-dihydroisoquinolin-1(2H)-one
|
1616289-36-1
|
C24H21BrCl2N2O2
|
|
1,1,3-Trimethyl-indan-4-ylamine hydrochloride
|
1616291-21-4
|
C12H18ClN
|
|
2,3-Dihydro-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid
|
1616337-50-8
|
C8H8N2O2
|
|
Methyl-5-(2,4-difluorobenzylcarbaMoyl)-1-(2,2-diMethoxyethyl)-3-Methoxy-4-oxo-1,4-dihydropyridine-2-carboxylate
|
1616340-68-1
|
C20H22F2N2O7
|
|
(2R,5S,13aR)-8-methoxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
|
1616340-94-3
|
C22H20F3N3O5
|
|
(2R,5S,13aR)-8-methoxy-7,9-dioxo-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxylic acid
|
1616342-45-0
|
C15H16N2O6
|
|
5-Octyl-α-ketoglutarate
|
1616344-00-3
|
C13H22O5
|
|
MonoMethyl FuMarate-d3
|
1616345-41-5
|
C5H3D3O4
|
|
NKHAVTQWNUWKEO-PWYLTMEHSA-N
|
1616345-45-9
|
C5H6O4
|
|
2-[[3-(4-chlorophenyl)propyl-methyl-amino]methyl]aniline
|
1616351-09-7
|
C17H21ClN2
|
|
SEL24-B489
|
1616359-00-2
|
C15H18Br2N4O2
|
|
6-Bromo-4,4-dimethyl-1,2,3,4-tetrahydroquinoline hydrochloride
|
1616370-88-7
|
C11H16ClNO
|
|
tert-butyl (2R,5S)-5-hydroxy-2-methylpiperidine-1-carboxylate
|
1616373-52-4
|
C11H21NO3
|
|
Trimethylsilyl 2,3,4,5-tetrafluorobenzoate
|
1616373-58-0
|
C10H10F4O2Si
|
|
2-Pyridinecarboxylic acid, 6-chloro-3-fluoro-, 1,1-dimethylethyl ester
|
1616378-54-1
|
C10H11ClFNO2
|
|
N-[3-[[5-Fluoro-2-[[4-[(2-methoxyethoxy)methoxy]phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide
|
1616380-54-1
|
C23H24FN5O4
|
|
1H-Pyrazole-3-carboxamide, 4,5-dimethyl-N-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-
|
1616385-51-3
|
C19H17N5O
|
|
Cyclopropyl(4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridin-1(2H)-yl)Methanone
|
1616388-38-5
|
C15H24BNO3
|
|
EPZ015666
|
1616391-65-1
|
C20H25N5O3
|
|
GSK591
|
1616391-87-7
|
C22H28N4O2
|
|
GSK-3326595
|
1616392-22-3
|
C24H32N6O3
|
|
4-Pyrimidinecarboxamide, 6-[(1-acetyl-4-piperidinyl)amino]-N-[(2R)-3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-
|
1616397-25-1
|
C24H32N6O3
|
|
9-[4-(4-bromophenyl)-6-phenyl-1,3,5-triazin-2-yl]-9H-Carbazole
|
1616413-67-2
|
C27H17BrN4
|
|
UCB9608
|
1616413-96-7
|
C20H26N8O2
|
|
4-(6-Amino-1,3-dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-methyl-piperazine-1-carboxylic acid tert-butyl ester
|
1616415-40-7
|
C17H27N7O2
|
|
CFI-400945 fumarate
|
1616420-30-4
|
C37H38N4O7
|
|
H2N-PEG11-CH2CH2COOH
|
1616426-12-0
|
C25H51NO13
|
|
Urea, N-[4-[2,3-dihydro-7-(5-methyl-1H-imidazol-2-yl)-1-oxo-1H-isoindol-4-yl]-3-fluorophenyl]-N'-(2,4,6-trifluorophenyl)-
|
1616428-23-9
|
C25H17F4N5O2
|
|
tert-butyl (3-amino-2,6-dichloropyridin-4-yl)carbamate
|
1616434-23-1
|
C10H13Cl2N3O2
|
|
(4aR,7aR)-octahydrocyclopenta[b][1,4]oxazine
|
1616435-00-7
|
C7H13NO
|
|
(4aR,7aR)-2,3,4,4a,5,6,7,7a-octahydrocyclopenta[b][1,4]oxazine
|
1616466-91-1
|
C7H13NO
|
|
UR-144 N-heptyl analog
|
1616469-06-7
|
C23H33NO
|
|
XLR11 Degradant
|
1616469-09-0
|
C21H28FNO
|
|
A-796260 Degradant
|
1616469-10-3
|
C22H30N2O2
|
|
N-[2-(Methacryloyloxy)ethyl]-N,N-dimethylbutan-1-aminium Bis(trifluoromethanesulfonyl)imide
|
1616483-28-3
|
C14H24F6N2O6S2
|
|
Tucidinostat (Chidamide)
|
1616493-44-7
|
C22H19FN4O2
|
|
2-(2-chloro-4-quinazolinyl)-9-phenyl-9H-Carbazole
|
1616499-37-6
|
C26H16ClN3
|
|
1,5-Difluoro-3-Methyl-2,4-dinitrobenzene
|
1616526-79-4
|
C7H4F2N2O4
|
|
1,5-Difluoro-3-Methyl-2-nitrobenzene
|
1616526-80-7
|
C7H5F2NO2
|
|
6-Chloro-3-Methoxy-2-nitropyridine
|
1616526-81-8
|
C6H5ClN2O3
|
|
5-HydroxypyriMidin-4(3H)-one hydrochloride
|
1616526-82-9
|
C4H5ClN2O2
|
|
IMidazo[1,5-a]pyridine-7-carboxylic acid dihydrochloride
|
1616526-83-0
|
C8H8Cl2N2O2
|
|
5-MethoxychroMan-4-ol
|
1616526-84-1
|
C10H12O3
|
|
5-Fluoro-1-Methyl-3-nitropyridin-2(1H)-one
|
1616526-85-2
|
C6H5FN2O3
|
|
Rivaroxaban iMpurity
|
1616563-62-2
|
C15H17N3O5
|
|
1,3-bis(3,5-dicarboxyphenyl)imidazoliumchloride
|
1616577-91-3
|
C19H13ClN2O8
|
|
Erythrinin D
|
1616592-59-6
|
C21H18O6
|
|
Erythrinin F
|
1616592-60-9
|
C20H18O7
|
|
Erythrinin G
|
1616592-61-0
|
C20H18O6
|
|
3,8-Dihydroxy-1,9-dimethoxy-11H-benzofuro[2,3-b][1]benzopyran-11-one
|
1616592-62-1
|
C17H12O7
|
|
(3-Chloro-2-fluoro-4-methoxyphenyl)methanol
|
1616601-81-0
|
C8H8ClFO2
|
|
2-(2-BroMophenyl)-9H-phenylcarbazole
|
1616607-88-5
|
C24H16BrN
|
|
(+)-Oxanthromicin
|
1616622-08-2
|
C36H30O12
|
|
TIC10
|
1616632-77-9
|
C24H26N4O
|
|
1,3-Di(pyren-1-yl)benzene
|
1616657-81-8
|
C38H22
|
|
Vildagliptin Related Compound G
|
1616662-84-0
|
C12H20N4O3
|
|
Tetrazine-NHS Ester
|
1616668-55-3
|
C14H11N5O4
|
|
3-((4-Methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)benzoic acid
|
1616670-62-2
|
C14H17F3N2O2
|
|
N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine
|
1616671-13-6
|
C25H46N6O4S
|
|
2-Amino-4-trifluoromethanesulfinyl-phenol
|
1616682-59-7
|
C7H6F3NO2S
|
|
Dodovisone A
|
1616683-50-1
|
C27H30O8
|
|
Dodovisone B
|
1616683-51-2
|
C27H32O9
|
|
Dodovisone C
|
1616683-52-3
|
C27H30O8
|
|
Dodovisone D
|
1616683-53-4
|
C22H22O8
|
|
Dodovislactone A
|
1616683-54-5
|
C18H26O4
|
|
Dodovislactone B
|
1616683-55-6
|
C21H30O5
|
|
1,1-bis(pyridin-2-ylmethyl)-2,2-bisimidazole
|
1616685-69-8
|
C18H16N6
|
|
[S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl]phenylmethyl]-2-methyl-2-propanesulfinamide
|
1616688-59-5
|
C29H30NOPS
|
|
[S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl](4-methoxyphenyl)methyl]-2-methyl-2-propanesulfinamide
|
1616688-62-0
|
C30H32NO2PS
|
|
[S(R)]-N-[(S)-[3,5-Bis(1,1-dimethylethyl)-4-methoxyphenyl][2-(diphenylphosphino)phenyl]methyl]-2-methyl-2-propanesulfinamide
|
1616688-63-1
|
C38H48NO2PS
|
|
[S(R)]-N-[(R)-[3,5-Bis(1,1-dimethylethyl)-4-methoxyphenyl][2-(diphenylphosphino)phenyl]methyl]-2-methyl-2-propanesulfinamide
|
1616688-64-2
|
C38H48NO2PS
|
|
[S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl]-1-naphthalenylmethyl]-2-methyl-2-propanesulfinamide
|
1616688-65-3
|
C33H32NOPS
|
|
Desidustat
|
1616690-16-4
|
C16H16N2O6
|
|
Ethyl 2-((cyclopropylmethoxy)amino)benzoate
|
1616691-65-6
|
C13H17NO3
|
|
Betrixaban Impurity 1
|
1616693-59-4
|
C22H20ClN5O3
|
|
tert-butyl (5-(2-chloroacetamido)pentyl)carbamate
|
1616693-72-1
|
C12H23ClN2O3
|
|
Creatine riboside
|
1616693-92-5
|
C9H17N3O6
|
|
2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate
|
1616703-93-5
|
C25H30F2N6O5S
|
|
(1S,3R)-3-(tert-butoxycarbonyl)-2,2-dimethylcyclobutanecarboxylicacid(WX192116)
|
1616705-60-2
|
C12H20O4
|
|
Ivabradine IMpurity
|
1616710-50-9
|
C27H35ClN2O6
|
|
1616710-52-1
|
1616710-52-1
|
C27H34N2O6
|
|
L-Ornithinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[[[[(2-aminoethyl)amino]carbonyl]oxy]methyl]phenyl]-
|
1616727-20-8
|
C31H46N8O8
|
|
Caesalpine A
|
1616757-59-5
|
C23H32O7
|
|
Caesalpine B
|
1616757-60-8
|
C23H30O7
|
|
Tofacitinib Impurity 2
|
1616760-97-4
|
C13H18ClN5
|
|
3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile
|
1616761-00-2
|
C16H19ClN6O
|
|
methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate
|
1616761-01-3
|
C17H23N5O3
|
|
2-Pyrimidinemethanamine, α-methyl-, hydrochloride (1:1)
|
1616809-52-9
|
C6H9N3.ClH
|
|
6-bromo-8-methoxy-3,4-dihydroquinazolin-4-one
|
1616828-53-5
|
C9H7BrN2O2
|
|
2-Amino-5-iodo-3-methoxy-benzoic acid
|
1616831-34-5
|
C8H8INO3
|
|
2-(4-bromophenyl)-4,6-di(naphthalen-2-yl)-1,3,5-triazine
|
1616841-66-7
|
C29H18BrN3
|
|
2H-Benzotriazole, 4,7-dibromo-5,6-difluoro-2-(1-octylnonyl)-
|
1616860-69-5
|
C23H35Br2F2N3
|
|
4,7-Bis(5-bromothiophen-2-yl)-5,6-difluoro-2-(heptadecan-9-yl)-2H-benzo[d][1,2,3]triazole
|
1616860-72-0
|
C31H39Br2F2N3S2
|
|
N-[2-[(tert-Butyldimethylsilyl)oxy]ethyl]oxetan-3-amine
|
1616924-64-1
|
C11H25NO2Si
|
|
methyl 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-3-carboxylate
|
1616930-45-0
|
C12H19BN2O4
|
|
3-(Ethoxycarbonyl)-1-methylpyrazole-5-boronic acid pinacol ester
|
1616930-46-1
|
C13H21BN2O4
|
|
(5-Bromo-4-chloro-2-iodo-phenyl)-methanol
|
1616954-87-0
|
C7H5BrClIO
|
|
N-[5-[1-Hydroxy-2-[[2-(4-methoxy-3-methylphenyl)-1-methylethyl](phenylmethyl)amino]ethyl]-2-(phenylmethoxy)phenyl]-formamide
|
1616967-25-9
|
C34H38N2O4
|
|
Formoterol EP Impurity E
|
1616967-26-0
|
C20H26N2O4
|
|
CAY10701
|
1616967-52-2
|
C24H19N3O2
|